(Q40405220)

20 September 2017

title

Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

20 September 2017

1 reference

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

G Marchesini

7

0 references

author name string

S Petta

1

1 reference

20 September 2017

S Ciminnisi

2

1 reference

20 September 2017

V Di Marco

3

1 reference

20 September 2017

D Cabibi

4

1 reference

20 September 2017

C Cammà

5

1 reference

20 September 2017

A Licata

6

1 reference

20 September 2017

A Craxì

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

27 December 2016

1 reference

Alimentary Pharmacology & Therapeutics

20 September 2017

published in

1 reference

20 September 2017

volume

45

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

510-518

1 reference

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

20 September 2017

cites work

1 reference

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Non-alcoholic fatty liver disease pathogenesis: the present and the future

21 January 2018

1 reference

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis.

21 January 2018

1 reference

Understanding sarcopenia as a geriatric syndrome

21 January 2018

1 reference

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.

21 January 2018

1 reference

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis

21 January 2018

1 reference

Impact of muscle wasting on survival in patients with liver cirrhosis

21 January 2018

1 reference

Sarcopenia impairs prognosis of patients with liver cirrhosis

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

21 January 2018

1 reference

Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

21 January 2018

1 reference

Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

ACE inhibitors, statins and thiazides: no association with change in grip strength among community dwelling older men and women from the Hertfordshire Cohort Study

21 January 2018

1 reference

Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II.

21 January 2018

1 reference

Roles for chemokines in liver disease

21 January 2018

1 reference

Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease

21 January 2018

1 reference

Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice

21 January 2018

1 reference

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

21 January 2018

1 reference

Sarcopenia and mortality after liver transplantation.

21 January 2018

1 reference

Impedance vector distribution by body mass index and conventional bioelectrical impedance analysis in obese women.

21 January 2018

1 reference

The potential of classic and specific bioelectrical impedance vector analysis for the assessment of sarcopenia and sarcopenic obesity

21 January 2018

1 reference

Accuracy of specific BIVA for the assessment of body composition in the United States population

21 January 2018

1 reference

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

21 January 2018

1 reference

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia

21 January 2018

1 reference

Sarcopenia from mechanism to diagnosis and treatment in liver disease

21 January 2018

1 reference

Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.13889

1 reference

20 September 2017

1 reference